Concord Drugs (BOM:538965) Marketable Securities : ₹0.0 Mil (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Concord Drugs Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Concord Drugs's Marketable Securities for the quarter that ended in Dec. 2023 was ₹0.0 Mil.

Concord Drugs's annual Marketable Securities stayed the same from Mar. 2021 (₹0.2 Mil) to Mar. 2022 (₹0.2 Mil) and stayed the same from Mar. 2022 (₹0.2 Mil) to Mar. 2023 (₹0.2 Mil).

Concord Drugs Marketable Securities Historical Data

The historical data trend for Concord Drugs's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Concord Drugs Marketable Securities Chart

Concord Drugs Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Marketable Securities

Get a 7-Day Free Trial

0.26

0.21

Concord Drugs Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Marketable Securities	Get a 7-Day Free Trial															-	0.21	-	2.10	-

Concord Drugs Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Concord Drugs (BOM:538965) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Concord Drugs Marketable Securities Related Terms

Thank you for viewing the detailed overview of Concord Drugs's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Concord Drugs (BOM:538965) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Concord Drugs Ltd (BOM:538965) » Definitions » Marketable Securities

Traded in Other Exchanges

N/A

Address

3-11-451, L B Nagar, Hayatnagar Mandal, Hyderabad, TG, IND, 500074

Website

https://www.concorddrugs.in

Concord Drugs Ltd is an India based pharmaceutical company. The principal activity of the company is to manufacture licensed drugs based on the formulations approved. Its product portfolio includes Pharmaceutical Ready to fill Pellets, MUPS ((Multiple Unit Pellets System); Tissue Bio Adhesive; Injectables (Small Volume Parenterals); Capsules; Liquid Orals (Syrups & Suspensions); Dry Syrups (Powder) and Hand Sanitizers. Geographically, it operates only in India.

Concord Drugs (BOM:538965) Headlines

No Headlines